Actos Bladder Cancer Settlement

Pharmaceutical giant Takeda has agreed to a $2.4 billion settlement to compensate plaintiffs who allege they developed bladder cancer after taking the diabetes medication, Actos® (pioglitazone). Officials at Takeda Pharmaceutical Co. said the offer will resolve a “vast majority” of the more than 8,000 Actos bladder cancer claims. In a press release, the company explained,...

read more

Jury Awards $9 Billion in Actos Litigation

In one of the largest jury awards in U.S. history, the manufacturers of the diabetes treatment Actos® were ordered to pay $1.5 million in compensatory damages and $9 billion in punitive damages over hidden cancer risks. According to court documents, a federal court jury found that pharmaceutical giants Takeda and Eli Lilly acted with...

read more